Navigation Links
Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008
Date:1/31/2008

UNION CITY, Calif., Jan. 31 /PRNewswire-FirstCall/ -- ABAXIS, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fiscal quarter ended December 31, 2007.
Highlights for the third quarter of fiscal 2008 include:

-- Revenues of $25.7 million, up 17% over last year's comparable quarter.

-- Medical market sales of $6.0 million, up 29% over last year's

comparable quarter.

-- Piccolo instrument sales of 238 units, up 45% over last year's

comparable quarter.

-- Veterinary hematology instrument sales of 301 units, up 44% over last

year's comparable quarter.

-- Veterinary reagent disc sales of $11.4 million, up 30% over last

year's comparable quarter.

-- Total medical and veterinary reagent disc sales of $14.3 million

compared to $11.3 million in the same period last year, up 26% over

last year's comparable quarter.

-- Operating income of $4.4 million, up 24% over last year's comparable

quarter.

-- Net income of $3.2 million, up 15% over last year's comparable

quarter.

-- Diluted EPS: $0.14 versus $0.13 in the same period last year.

-- Cash, cash equivalents and short-term investments as of December 31,

2007 of $55.8 million, up 32% compared to December 31, 2006.

Quarterly Results: For the fiscal quarter ended December 31, 2007, Abaxis reported revenues of $25.7 million, as compared with revenues of $22.0 million for the comparable period last year, an increase of 17 percent. Instrument, reagent disc and hematology reagent revenues increased by an aggregate of $3.1 million, or 15 perc
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Abaxis to Present at the CL King Best Ideas Conference 2007
2. Abaxis Launches The VetScan(R) HM5 a State-of-the-Art 5-Part Differential Veterinary Hematology Analyzer
3. Abaxis to Present at the 2007 UBS Global Life Science Conference
4. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
5. Abaxis to Report Second Quarter Fiscal 2008 Financial Results Wednesday, October 24, 2007
6. Abaxis Announces Appointment of New Distribution Partner in Japan
7. Abaxis Announces First Ever CLIA-Waived Comprehensive Metabolic Panel
8. Abaxis, Inc. to Present at the Fifth Annual Sidoti & Company Emerging Growth Conference
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 Novellus Healthcare ... Care: Pharmacy & Clinics™, an independent journal that ... treating and caring for patients inside the pharmacy ... expands to provide optimal access to quality care, ... forum for the team treating and coordinating patient ...
(Date:12/19/2014)... Slone Partners , a ... healthcare information technology, and laboratory testing industries, has ... Operating Officer. The announcement comes after a year ... strengthened presence in Boston and several new additions ... breathes the client experience," said Adam Slone, Chief ...
(Date:12/19/2014)... (HealthDay News) -- Being in good shape seems to reduce ... looked at data from more than 57,000 Americans, including more ... between 1991 and 2009. Those in the poorest shape ... blood pressure at the start of the study, compared to ... fitness. Of the more than 8,000 people diagnosed with ...
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- Traveling through the ... measles virus to three others within a four-hour time ... a new report shows. "The exposures in this ... rather than an international terminal, highlighting the fact that ... Jared Vega, an infectious disease specialist at the U.S. ...
(Date:12/17/2014)... Unidesk Corporation today announced that ... welcomed its inaugural class in August 2013, has ... support bring your own device (BYOD) and deliver ... The solution, comprised of Citrix XenDesktop ... and storage infrastructure and Unidesk virtual ...
Breaking Medicine News(10 mins):Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3
... May 6 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... quarter ended March 31, 2009.Total revenue for the first ... loss of $8.4 million, including $1.9 million of restructuring ... and marketable securities totaled $4.3 million, with no debt ...
... leading university hospital has begun treatments using a new, ... improve outcomes while extending modern care to more patients. ... was the first patient in the country to be ... VAR ).Clinicians at Ajou University Hospital in ...
... /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin Board: ... developer,and a leading distributor of prescription and ... nutritional and dietary supplements, and,medical devices and ... conduct,a conference call at 9:00 a.m. Eastern ...
... (Nasdaq: EFJI ) today announced its results for ... $11.5 million, or 34%, to $22.4 million for the three ... same period in 2008. This anticipated quarterly decline was attributable ... associated with the FCC re-banding effort. "While our state and ...
... NeoStem, Inc. (NYSE Amex: NBS ), which ... of adult stem cells for future medical need, has ... technology of Vincent C. Giampapa, M.D., F.A.C.S. relating ... February 2009.The newest adult stem cell collection center in ...
... NUCRYST Pharmaceuticals Corp., a developer and manufacturer of medical products ... for the first quarter of 2009. , For the quarter ... $1.1 million, or $0.06 cents per share, on revenues of ... million, or $0.12 cents per share, on revenues of $5.2 ...
Cached Medicine News:Health News:Sunesis Reports Financial Results for the First Quarter 2009 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 3Health News:Sunesis Reports Financial Results for the First Quarter 2009 4Health News:Sunesis Reports Financial Results for the First Quarter 2009 5Health News:Sunesis Reports Financial Results for the First Quarter 2009 6Health News:Sunesis Reports Financial Results for the First Quarter 2009 7Health News:Sunesis Reports Financial Results for the First Quarter 2009 8Health News:Sunesis Reports Financial Results for the First Quarter 2009 9Health News:Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Health News:Ajou University Hospital Becomes First in Korea to Treat Using RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Health News:China Medicine Announces Conference Call to Discuss First Quarter 2009 Results 2Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 2Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 3Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 4Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 5Health News:EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results 6Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 3Health News:NUCRYST announces 2009 first quarter financial results 2Health News:NUCRYST announces 2009 first quarter financial results 3Health News:NUCRYST announces 2009 first quarter financial results 4Health News:NUCRYST announces 2009 first quarter financial results 5Health News:NUCRYST announces 2009 first quarter financial results 6Health News:NUCRYST announces 2009 first quarter financial results 7
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. (NYSE ... closing of its offering of $125 million aggregate principal ... "Notes").  The Notes were offered and sold only to ... Securities Act of 1933, as amended (the "Securities Act"). ... rate of 3.75% per year, payable semiannually in arrears ...
(Date:12/17/2014)... Dec. 17, 2014 PCCA received the ... ( http://bit.ly/1382OkS ) program seal for best practices ... program highlights medical practices, materials and goods that ... Children affected by autism often have ... exacerbated by ingredients found in food and medicine ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram ... by 2016. The North America ... share while Europe claims approximately ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4
... Epiphany Biosciences announced,today, the initiation of a Phase ... and management of acute infectious,mononucleosis. Currently, there are ... condition or any other disease caused by,the Epstein-Barr ... spectrum of anti-viral activity,including inhibition of viral replication ...
... 6 Some 5,000 COPD patients will be ... (Alpha-1) in,a study marking a major cooperative effort ... Respiratory Care (AARC)., The principal investigator is ... Pulmonary Medicine, National Jewish Medical and Research Center,in ...
Cached Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: